Grave prognosis of the musclespecific kinase (MuSK)-positive myasthenia gravis (MG): A false prejudice

Grave prognosis of the musclespecific kinase (MuSK)-positive myasthenia gravis (MG): A false prejudice

Bibliographic Details
Main Author:	Fu Liong Hiew
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Annals of Indian Academy of Neurology
Online Access:	http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=1;spage=6;epage=6;aulast=Hiew

Similar Items

MuSK (Muscle Specific Kinase) positive myasthenia: Grave prognosis or undue prejudice?
by: Priyanka Samal, et al.
Published: (2020-01-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
by: Koneczny, I, et al.
Published: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
by: Koneczny, I, et al.
Published: (2014)

Myasthenia gravis with MuSK antibodies
by: Farrugia, M, et al.
Published: (2005)

Potential mechanisms in MuSK-myasthenia gravis
by: Koneczny, I
Published: (2014)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
by: Lee, J, et al.
Published: (2006)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
by: McConville, J, et al.
Published: (2004)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
by: Vincent, A, et al.
Published: (2006)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
by: Carmelo Rodolico, et al.
Published: (2020-07-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
by: Shan CAO, et al.
Published: (2019-02-01)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
by: Bennett, D, et al.
Published: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
by: Diana Epure, et al.
Published: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
by: Ting LI, et al.
Published: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
by: Yung-Chuan Huang, et al.
Published: (2008-07-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
by: Newsom-Davis, J, et al.
Published: (2001)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
by: Chang, T, et al.
Published: (2009)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
by: Phillips, W, et al.
Published: (2015)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
by: Amber Eker, et al.
Published: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
by: Zunwei Zhang, et al.
Published: (2020-10-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
by: Shiraishi, H, et al.
Published: (2005)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
by: Yeh, J, et al.
Published: (2004)

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
by: Edyta Dziadkowiak, et al.
Published: (2024-03-01)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
by: Christiane Schneider-Gold, et al.
Published: (2017-10-01)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
by: Hoch, W, et al.
Published: (2001)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
by: Lee, J, et al.
Published: (2016)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
by: Aigli G. Vakrakou, et al.
Published: (2023-07-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
by: Vuslat Yilmaz, et al.
Published: (2015-01-01)

MuSK Myasthenia Gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine
by: Yirui Xie, et al.
Published: (2020-09-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
by: Deymeer, F, et al.
Published: (2007)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
by: Farrugia, M, et al.
Published: (2007)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
by: Niks, E, et al.
Published: (2006)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
by: Farrugia, M, et al.
Published: (2006)

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis
by: Umberto Basile, et al.
Published: (2021-08-01)

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
by: Leite, M, et al.
Published: (2005)

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study
by: Meng X, et al.
Published: (2022-05-01)

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.
by: Nazanin Ghazanfari, et al.
Published: (2014-01-01)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
by: Farrugia, M, et al.
Published: (2007)

Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
by: Bhibhatbhan, A, et al.
Published: (2007)

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
by: Inga Koneczny, et al.
Published: (2024-04-01)